Skip Navigation


JAC Advance Access originally published online on April 27, 2005
Journal of Antimicrobial Chemotherapy 2005 55(6):995-1002; doi:10.1093/jac/dki109
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/6/995    most recent
dki109v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (26)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yin, L.-Y.
Right arrow Articles by Calhoun, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, L.-Y.
Right arrow Articles by Calhoun, J. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model

Li-Yan Yin1, Luca Lazzarini2, Fan Li3, C. Melinda Stevens3 and Jason H. Calhoun1,*

1 Department of Orthopaedic Surgery, University of Missouri, Columbia, MO, USA; 2 Infectious Diseases Unit, Department of Internal Medicine, San Bortolo Hospital, Vicenza, Italy; 3 Department of Orthopedics and Rehabilitation, The University of Texas Medical Branch, Galveston, TX, USA

* Corresponding author. Tel: +1-573-882-7189; Fax: +1-573-882-1760; Email: calhounj{at}health.missouri.edu

Objectives: Staphylococcus aureus is the most common organism isolated in osteomyelitis. Methicillin-resistant S. aureus (MRSA) infections are particularly difficult to treat. We evaluated the efficacy of tigecycline and vancomycin with and without rifampicin in a rabbit model of MRSA osteomyelitis.

Methods: A 28 day antibiotic therapy with a subcutaneous injection of tigecycline (14 mg/kg twice daily), with and without oral rifampicin (40 mg/kg twice daily); or subcutaneous administration of vancomycin (30 mg/kg twice daily), with and without oral rifampicin (40 mg/kg twice daily) were compared. Osteomyelitis was induced with an intramedullary injection of 106 colony-forming units of MRSA. Infected rabbits were randomly divided into six groups: tigecycline, tigecycline with oral rifampicin, vancomycin, vancomycin with oral rifampicin, and no treatment control and tigecycline bone penetration groups. Treatment began 2 weeks after infection. After 4 weeks of therapy, the rabbits were left untreated for 2 weeks. Rabbits were then euthanized, and the tibias were harvested. The bones were cultured, and bacterial counts of MRSA were performed.

Results: Rabbits that received tigecycline and oral rifampicin therapy (n=14) showed a 100% infection clearance. Rabbits treated with tigecycline (n=10) showed a 90% clearance. Rabbits treated with vancomycin and oral rifampicin (n=10) also showed a 90% clearance. Rabbits treated with vancomycin (n=11) showed an 81.8% clearance. Untreated controls (n=15) demonstrated only a 26% clearance. For the tigecycline bone penetration group, the bone concentrations of tigecycline in the infected tibia were significantly higher than the non-infected ones.

Conclusions: Tigecycline may be an effective alternative to vancomycin in the treatment of MRSA osteomyelitis.

Keywords: MRSA , antibiotics , infections


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
G. Amador, H. Gautier, V. Le Mabecque, A. F. Miegeville, G. Potel, J.-M. Bouler, P. Weiss, J. Caillon, and C. Jacqueline
In Vivo Assessment of the Antimicrobial Activity of a Calcium-Deficient Apatite Vancomycin Drug Delivery System in a Methicillin-Resistant Staphylococcus aureus Rabbit Osteomyelitis Experimental Model
Antimicrob. Agents Chemother., February 1, 2010; 54(2): 950 - 952.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
P. Vaudaux, B. Fleury, A. Gjinovci, E. Huggler, M. Tangomo-Bento, and D. P. Lew
Comparison of Tigecycline and Vancomycin for Treatment of Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureus
Antimicrob. Agents Chemother., July 1, 2009; 53(7): 3150 - 3152.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
F. K. Gould, R. Brindle, P. R. Chadwick, A. P. Fraise, S. Hill, D. Nathwani, G. L. Ridgway, M. J. Spry, R. E. Warren, and on behalf of the MRSA Working Party of the British
Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom
J. Antimicrob. Chemother., May 1, 2009; 63(5): 849 - 861.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. E. Bowker, A. R. Noel, and A. P. MacGowan
Pharmacodynamics of Minocycline against Staphylococcus aureus in an In Vitro Pharmacokinetic Model
Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4370 - 4373.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
L.-Y. Yin, J. H. Calhoun, J. K. Thomas, S. Shapiro, and A. Schmitt-Hoffmann
Efficacies of Ceftobiprole Medocaril and Comparators in a Rabbit Model of Osteomyelitis Due to Methicillin-Resistant Staphylococcus aureus
Antimicrob. Agents Chemother., May 1, 2008; 52(5): 1618 - 1622.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
J. Perlroth, M. Kuo, J. Tan, A. S. Bayer, and L. G. Miller
Adjunctive Use of Rifampin for the Treatment of Staphylococcus aureus Infections: A Systematic Review of the Literature
Arch Intern Med, April 28, 2008; 168(8): 805 - 819.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
M. Stanzani, F. Tumietto, M. B. Giannini, G. Bianchi, A. Nanetti, N. Vianelli, M. Arpinati, M. Giovannini, F. Bonifazi, G. Bandini, et al.
Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline
J. Med. Microbiol., December 1, 2007; 56(12): 1692 - 1695.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.